Current Pharmaceutical Design
Title:Editorial: Natural Products as the Integral Part of the Therapy?
Volume: 23 Issue: 17
Author(s): Maciej Banach*, Dimitri P. Mikhailidis, Maria-Corina Serban and Amirhossein Sahebkar
Affiliation:
- Department of Hypertension WAM University Hospital in Lodz Medical University of Lodz Zeromskiego 113; 90-549 Lodz,Poland
Export Options
About this article
Cite this article as:
Banach Maciej*, Mikhailidis P. Dimitri , Serban Maria-Corina and Sahebkar Amirhossein , Editorial: Natural Products as the Integral Part of the Therapy?, Current Pharmaceutical Design 2017; 23 (17) . https://dx.doi.org/10.2174/1381612823999170404122553
DOI https://dx.doi.org/10.2174/1381612823999170404122553 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
What Changes we may Expect in 2010 Hypertension Diagnosis and Management: Insights from the European Update Document
Current Vascular Pharmacology Editorial [Hot Topic: Appetite Regulation: Future Directions in Obesity Treatment (Guest Editor: Jason C.G. Halford)]
Current Drug Targets Development and Characterization of Nasal Delivery of Selegiline Hydrochloride Loaded Nanolipid Carriers for the Management of Parkinson’s Disease
Central Nervous System Agents in Medicinal Chemistry Meet Our Regional Editor Ryuichi Morishita
Current Hypertension Reviews HMG-CoA Reductase Inhibitors: Effects on Chronic Subacute Inflammation and Onset of Atherosclerosis Induced by Dietary Cholesterol
Current Drug Targets - Cardiovascular & Hematological Disorders Dietary Regulation of Glucose Metabolism in Metabolic Syndrome
Current Vascular Pharmacology Editorial [Hot Topic: Recent Advances on Bioactive Lipids (Guest Editor: Diana Martin & Montserrat Gonzalez)]
Current Nutrition & Food Science Oral Glucose-lowering Drugs and Cardiovascular Outcomes: From the Negative RECORD and ACCORD to Neutral TECOS and Promising EMPA-REG
Current Vascular Pharmacology The Role of Asymmetric Dimethylarginine (ADMA) in Endothelial Dysfunction and Cardiovascular Disease
Current Cardiology Reviews Cilostazol in the Management of Atherosclerosis
Current Vascular Pharmacology Cystatin C, Adipokines and Cardiovascular Risk in HIV Infected Patients
Current HIV Research Elderly Hypertensive Patients: Silent White Matter Lesions, Blood Pressure Variability, Baroreflex Impairment and Cognitive Deterioration
Current Hypertension Reviews Chemokines as Potential Therapeutic Targets in Atherosclerosis
Current Drug Targets Possible Consequences of Blocking Transient Receptor Potential Vanilloid 1
Current Pharmaceutical Biotechnology EGF Receptor as a Drug Target in Arterial Hypertension
Mini-Reviews in Medicinal Chemistry Hypertension and Angiogenesis
Current Pharmaceutical Design Endothelin-1 and Endothelin Converting Enzyme-1 in Human Atherosclerosis - Novel Targets for Pharmacotherapy in Atherosclerosis
Current Vascular Pharmacology Sunitinib in the Treatment of Thyroid Cancer
Current Medicinal Chemistry Loss of Eyebrows and Eyelashes During Concomitant Treatment with Sitagliptin and Metformin
Current Drug Safety Drug Repositioning for Treatment of Movement Disorders: From Serendipity to Rational Discovery Strategies
Current Topics in Medicinal Chemistry